STOCK TITAN

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) has announced its participation in several upcoming investor conferences. Key events include the Cowen 41st Annual Health Care Conference on March 1 at 2:40 p.m. ET, the H.C. Wainwright Global Life Sciences Conference on March 9 at 7:00 a.m. ET, and the Barclays Global Healthcare Conference on March 10 at 10:55 a.m. ET. Live webcasts will be available on the company’s website under the Investors and Media section. Sangamo is focused on developing genomic medicines through innovative therapies.

Positive
  • None.
Negative
  • None.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

  • Cowen 41st Annual Health Care Conference
    Date: Monday, March 1st at 2:40 p.m. Eastern Time
  • H.C. Wainwright Global Life Sciences Conference
    Date: Tuesday, March 9th at 7:00 a.m. Eastern Time
  • Barclays Global Healthcare Conference
    Date: Wednesday, March 10th at 10:55 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

FAQ

What are the dates for the investor conferences Sangamo Therapeutics is attending in March 2023?

Sangamo Therapeutics will participate in the following investor conferences in March 2023: Cowen 41st Annual Health Care Conference on March 1, H.C. Wainwright Global Life Sciences Conference on March 9, and Barclays Global Healthcare Conference on March 10.

What time will Sangamo present at the Cowen 41st Annual Health Care Conference?

Sangamo Therapeutics is scheduled to present at the Cowen 41st Annual Health Care Conference on March 1 at 2:40 p.m. Eastern Time.

Where can I find the webcast for Sangamo's presentations?

Webcasts of Sangamo's presentations will be available on their website in the Investors and Media section under Events and Presentations.

What is the focus of Sangamo Therapeutics as a company?

Sangamo Therapeutics is dedicated to developing genomic medicines utilizing gene therapy, cell therapy, and genome engineering to transform patients' lives.

What is the stock symbol for Sangamo Therapeutics?

The stock symbol for Sangamo Therapeutics is SGMO.

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

SGMO Rankings

SGMO Latest News

SGMO Stock Data

407.90M
202.87M
2.38%
27.08%
9.11%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
RICHMOND